December seasonality after the November jobs report can turn weak until the later part of the month. Buying positions in bullish sectors is useful during this period. Oil and energy stocks perform well, while gold and silver enter a weak period.
Christopher Davies Tags: Seasonal Strategy, Seasonality
A very early stage biotech opportunity with links to big pharma. We are seeing small scattered call buying today.
Christopher Davies Tags: Biotech, COVID, GLD, Gold, IBB, TAN, xbi
Black Friday Sales are expected to be dominated by online shopping with overall sales increasing by 5% from 2019. Is this a low estimate?
Biotech and Solar ETFs breakout, while gold broke down this week.
Christopher Davies Tags: NASDAQ, QQQ, Russell 1000, Russell 2000, Seasonal Strategy, SPY
We are following up on a recent IPO idea published on our telegram channel. This Medtech company looks towards a post COVID expansion in Europe and Asia.
This early stage media company sells at 20% percent discounted valuation to Netflix. It has double the revenue growth, higher margins and its service is only priced at $15/year!
The move from Growth stocks to Value names has been quick and decisive. We look at a big name tech stock to take advantage of a rotation back into growth.
Christopher Davies Tags: AT&T, bitcoin, dividend, Exxon, GLD, IBM, Tech